Cidara was founded in 2012.
Cidara was incorporated in Delaware in December 2012 as K2 Therapeutics, Inc. and its name was changed to Cidara Therapeutics, Inc. in July 2014.
6310 Nancy Ridge Drive, Suite 101
San Diego, CA 92121
Ernst & Young LLP
Cidara is traded on The NASDAQ Global Market under the symbol “CDTX.”
Cidara went public on April 15, 2015.
Shares can be purchased through a stockbroker of your choice.
Cidara does not currently offer a direct stock purchase plan.
Currently, Cidara does not offer a dividend or a dividend reinvestment program
Cidara’s transfer agent is America Stock Transfer & Trust Company, LLC. You can find more information about how to contact America Stock Transfer & Trust Company at:
American Stock Transfer & Trust Company, LLC.
6201 15th Avenue
Brooklyn, New York 11219
Please contact our transfer agent American Stock Transfer & Trust Company, LLC. (AST) at https://www.amstock.com or 800-937-5449. Our Transfer Agent can look up your records and make any necessary adjustments. There is a fee involved for replacing lost certificates.
How can I get a copy of your Annual Report or any other investor materials such as an Investor Relations kit or 10-K?
Quarterly & Annual Reports and other investor materials, when available, can be found in the “SEC Filings” section of our corporate website. Additionally, all SEC filings can be accessed directly from the SEC at http://www.sec.gov.